Peter Morsing, Chief Executive Officer


CEO since December 2017. PhD in Physiology from Lund University. Peter has over 20 years of experience from the pharmaceutical and biotechnology industry, where he has been active in preclinical development, strategy work and business development. For several years he worked in a variety of positions, both within the Department of Pharmacology as well as Global Strategy and Business Development at AstraZeneca. He has also operated as portfolio manager at the Second AP Fund with responsibility for the Swedish and European pharmaceutical and biotechnology portfolios. Peter earlier had the position as Chief Operating Officer of Vaccinogen Inc.